Related Experiment Videos
[Nutrition therapy for gestational diabetes]
1Else Kröner-Fresenius-Zentrum für Ernährungsmedizin, Technische Universität München, Am Forum 5, 85350 Freising-Weihenstephan. ulrike.amann-gassner@wzw.tum.de
Deutsche Medizinische Wochenschrift (1946)
|April 17, 2008
Summary
Managing gestational diabetes mellitus (GDM) requires adequate nutrition and blood glucose monitoring. Individualized dietary plans, focusing on carbohydrate intake, are key for successful GDM management in overweight women.
Area of Science:
- Obstetrics and Gynecology
- Nutritional Science
- Endocrinology
Background:
- Overweight and excessive pre-conception energy intake are significant risk factors for gestational diabetes mellitus (GDM).
- Maternal nutrition can influence fetal programming, potentially impacting long-term infant health.
- Effective GDM management aims for normoglycemia through diet and blood glucose monitoring.
Purpose of the Study:
- To review the current understanding of nutritional management in overweight and obese women with GDM.
- To address uncertainties regarding optimal dietary macronutrient composition and calorie restriction strategies.
Main Methods:
- Review of existing literature and interventional studies on GDM nutritional management.
- Analysis of data concerning carbohydrate intake, meal distribution, and calorie restriction.
Main Results:
- Adequate energy and nutrient intake are crucial for GDM treatment.
- Carbohydrate intake ranging from 40-55% of total energy is generally acceptable.
- Individualized nutritional strategies combined with lifestyle interventions are principal components of GDM management.
Conclusions:
- Normoglycemia can often be achieved with adequate nutrition and self-monitoring.
- Further interventional studies are needed to define optimal dietary strategies for GDM in overweight/obese women.
- Individualized nutritional treatment is essential for effective GDM management.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...